Two recently finalized guidance documents update the US Food and Drug Administration’s requirements around clearances and waivers for diagnostic tests that can be performed outside laboratory settings.
The Clinical Laboratory Improvement Amendments, or CLIA, require that tests meeting a certain standard of complexity be performed in a certified clinical laboratory. For a test to be performed outside...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?